Advocate Group LLC Astrazeneca PLC Transaction History
Advocate Group LLC
- $531 Million
- Q4 2024
A detailed history of Advocate Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Advocate Group LLC holds 12,686 shares of AZN stock, worth $876,095. This represents 0.16% of its overall portfolio holdings.
Number of Shares
12,686
Previous 12,692
0.05%
Holding current value
$876,095
Previous $988,000
15.89%
% of portfolio
0.16%
Previous 0.18%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,340Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.34 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.9 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.57 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.54 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.32 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...